The global CAR T-cell therapy market is experiencing explosive growth, driven by growing demand for innovative cancer treatments. This therapy involves modifying a patient's own immune cells to destroy cancer cells, offering hopeful results in the treatment of numerous blood cancers. Leading factors contributing market expansion include advancement